Literature DB >> 2056331

Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease.

K W Lange, F R Wells, M N Rossor, P Jenner, C D Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2056331      PMCID： PMC488503          DOI： 10.1136/jnnp.54.4.373-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Brain muscarinic receptors in Alzheimer's and Parkinson's diseases.

Authors:  K W Lange; F R Wells; M N Rossor; P Jenner; C D Marsden
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321

2.  Nicotinic stimulation of [3H]acetylcholine release from mouse cerebral cortical synaptosomes.

Authors:  P P Rowell; D L Winkler
Journal:  J Neurochem       Date:  1984-12       Impact factor: 5.372

3.  A post-mortem study of the cholinergic and GABA systems in senile dementia.

Authors:  M N Rossor; N J Garrett; A L Johnson; C Q Mountjoy; M Roth; L L Iversen
Journal:  Brain       Date:  1982-06       Impact factor: 13.501

4.  Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

Authors:  M Ruberg; A Ploska; F Javoy-Agid; Y Agid
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

5.  Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

Authors:  E K Perry; M Curtis; D J Dick; J M Candy; J R Atack; C A Bloxham; G Blessed; A Fairbairn; B E Tomlinson; R H Perry
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-05       Impact factor: 10.154
  5 in total
  2 in total

1.  Treatment of Alzheimer's disease.

Authors:  D M Bowen; P T Francis; A W Procter; A B Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

2.  Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease.

Authors:  Beate Ritz; Pei-Chen Lee; Christina F Lassen; Onyebuchi A Arah
Journal:  Neurology       Date:  2014-09-12       Impact factor: 9.910
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.